M RE4 (Ropinirole hydrochloride extended-release 4 mg)

Pill imprint M RE4 has been identified as Ropinirole hydrochloride extended-release 4 mg.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for M RE4 (Ropinirole hydrochloride extended-release 4 mg)

Ropinirole hydrochloride extended-release 4 mg M RE4
Ropinirole hydrochloride extended-release
Imprint:
M RE4
Strength:
4 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web1)